Researcher
Yves Debaveye
- Disciplines:Anaesthesiology, Intensive care and emergency medicine
Affiliations
- Laboratory of Intensive Care Medicine (Division)
Member
From1 Oct 2002 → Today
Projects
1 - 6 of 6
- Optimizing Antibacterial Dosing in Special Patient PopulationsFrom24 Jan 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- STRAtified Dosing based on Augmented renal clearance for CEFtriaxone in patients with severe community-acquired pneumonia: STRADA-CEF trial.From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Antibacterial dose optimisation based on augmented renal clearance in adult critically ill patients and selected pediatric patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Mold-active Azoles: Development, Validation and Implementation of strategies for Safe and Effective Dosing (M-ADVISED)From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Clinical validation of antifungal dosing strategies in critically ill patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- ANTIBACTERIAL DOSING IN SPECIAL PATIENT POPULATIONS WITH SEVERE BACTERIAL INFECTIONS: A PATIENT-ORIENTED AND COVARIATE-DRIVEN APPROACHFrom1 Oct 2016 → 30 Sep 2021Funding: BOF - Doctoral projects, BOF - doctoral mandates
Publications
41 - 50 of 91
- A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation(2021)
Authors: Ruth Van Daele, Yves Debaveye, Joost Wauters, Christophe Vandenbriele
- Timeliness of administration of amoxicillin-clavulanic acid and meropenem in a large tertiary care centre(2021)
Authors: Astrid Van Wilder, Luk Bruyneel, Willy Peetermans, Yves Debaveye, Kris Vanhaecht
Pages: 1651 - 1659 - Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort Analysis(2021)
Authors: Matthias Gijsen, Erwin Dreesen, Pieter Annaert, Yves Debaveye, Joost Wauters
- Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?(2021)
Authors: Ruth Van Daele, Yves Debaveye, Katrien Lagrou, Isabel Spriet
- Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial(2021)
Authors: Lore Vanderbeke, Yves Debaveye, Simon Feys, Greet Hermans, Katrien Lagrou, Johan Maertens, Karin Thevissen, Ruth Van Daele, Alexander Wilmer, Joost Wauters
Pages: 674 - 686 - Five-year outcome of respiratory muscle weakness at intensive care unit discharge: secondary analysis of a prospective cohort study(2021)
Authors: Nathalie Van Aerde, Yves Debaveye, Alexander Wilmer, Jan Gunst, Michael Casaer, Joost Wauters, Rik Gosselink, Greet Van den Berghe, Greet Hermans
Pages: 561 - 567 - Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study(2021)
Authors: Matthias Gijsen, Erwin Dreesen, Ruth Van Daele, Pieter Annaert, Yves Debaveye, Joost Wauters
- Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation(2021)
Authors: Ruth Van Daele, Erwin Dreesen, Matthias Gijsen, Yves Debaveye, Joost Wauters
Pages: 1234 - 1241 - Meropenem Stability in Human Plasma at-20 °C: Detailed Assessment of Degradation(2021)
Authors: Matthias Gijsen, Benjamin Filtjens, Pieter Annaert, Yves Debaveye, Joost Wauters, Peter Slaets
- ESC Textbook of Intensive and Acute Cardiovascular Care (3rd edition)(2021)
Authors: Jan Gunst, Yves Debaveye, Greet Van den Berghe
Pages: 912 - 925Number of pages: 24